$1.490
-0.010 (-0.67%)At close
CRIS Comparative Benchmarking
In the context of the broader market, CRIS competes directly with industry leaders such as BCAB and CHGA. With a market capitalization of $4.37M, it holds a leading position in the sector. When comparing efficiency, CRIS's gross margin of N/A stands against BCAB's 100.00% and CHGA's N/A. Such benchmarking helps identify whether Curis Inc is trading at a premium or discount relative to its financial performance.
Curis Inc Financial Performance
Curis reported total revenue of $2.93 million in Q3 2024, but faced a net loss of $24.2 million in Q1 2026, reflecting ongoing financial challenges. Despite this, the gross margin was exceptionally high at 104.37% in Q3 2024, indicating strong product profitability when operational issues are resolved.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.